Publications
- Lenalidomide treatment in myelodysplastic syndrome with 5q deletion - Czech MDS group experience2015 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
- Impact of immunomodulatory drugs in treatment of primary myelofibrosis2015 | Faculty of Medicine in Hradec Králové
- Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q-MDS (IPSS low and intermediate-1)2012 | Publication without faculty affiliation
- Analysis of myelodysplastic syndrome patients with deletion of long arm chromosome 5 followed up by the Czech MDS Working Group. Significance for the diagnostic and prognostic assessment2009 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Analysis of myelodysplastic syndrome patients with deletion of long arm chromosome 5 followed up by the Czech MDS Working Group. Significance for the diagnostic and prognostic assessment2009 | Faculty of Medicine in Hradec Králové
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen
- The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib2024 | First Faculty of Medicine
- Immune deregulation in myelodysplastic syndromes - the role of cytokines and soluble adhesion molecules. A pilot study2023 | Faculty of Medicine in Hradec Králové
- Treatment of polycythemia vera with ropeginterferon alfa‑2b in a young woman with a successful pregnancy – case report2023 | Faculty of Medicine in Hradec Králové
- Karotidynie (TIPIC syndrom) u pacientky s paroxysmální noční hemoglobinurií2022 | Faculty of Medicine in Hradec Králové
Loading network view...